<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27068220</article-id>
      <article-id pub-id-type="pmc">4828799</article-id>
      <article-id pub-id-type="publisher-id">2022</article-id>
      <article-id pub-id-type="doi">10.1186/s13104-016-2022-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Unforeseeable presentation of <italic>Chryseobacterium indologenes</italic> infection in a paediatric patient</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Srinivasan</surname>
            <given-names>Geethalakshmi</given-names>
          </name>
          <address>
            <email>drgitasrinivasan@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Muthusamy</surname>
            <given-names>Swapna</given-names>
          </name>
          <address>
            <email>swapnamuthuswamy@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Raveendran</surname>
            <given-names>Vinod</given-names>
          </name>
          <address>
            <email>vrnair@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Joseph</surname>
            <given-names>Noyal Mariya</given-names>
          </name>
          <address>
            <email>noyaljoseph@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Easow</surname>
            <given-names>Joshy Maducolil</given-names>
          </name>
          <address>
            <email>dr.jmeasow@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Microbiology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Ariyur, Puducherry, 605 102 India </aff>
        <aff id="Aff2"><label/>Department of Microbiology, JIPMER, Puducherry, 605 005 India </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>12</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>212</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>4</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Srinivasan et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>
We report for the first time a case of community acquired <italic>Chryseobacterium indologenes</italic> soft tissue infection in an immunocompetent patient.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 11&#xA0;year female child, from South-Asia of Indian origin presented with fever, pain and swelling in right leg for 3&#xA0;days with no significant past history. Incision and drainage was done and pus was sent for culture and sensitivity. Radiological investigation showed subtle irregular soft tissue density. Pus culture grew multidrug resistant <italic>C. indologenes.</italic></p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Though of low pathogenicity, our case emphasises its unpredictable nature and the need to determine minimum inhibitory concentration breakpoints for therapy.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Case report</kwd>
        <kwd>Cellulitis</kwd>
        <kwd>
          <italic>Chryseobacterium indologenes</italic>
        </kwd>
        <kwd>Soft-tissue infection</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Previously known as <italic>Flavobacterium</italic>, the genus <italic>Chryseobacterium</italic> comprising six species are non-glucose fermenting bacilli. <italic>Chryseobacterium indologenes</italic> species was first isolated in 1993 from tracheal aspirate of a patient complicated with ventilator associated pneumonia. The clinical significance of the infections due to <italic>C. indologenes</italic> is poorly studied as not many cases are reported in literature and is also a rare human pathogen. Commonly seen in the environment, these are known to cause a spectrum of infections usually in hospitalized and immunocompromised patients, and in infants. Here we describe a case of <italic>C. indologenes</italic> infection in an immunocompetent child.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 11&#xA0;year old female child from South-Asia of Indian origin, presented to the orthopaedics department with complaints of fever, non-traumatic pain and swelling in the right leg for about 3&#xA0;days. There was no significant past history. She was septic and was noted to have a diffuse swelling over the upper third of right leg with skin erythema, warmth and tenderness. No discharging sinuses were noted. Blood investigations showed a raised white cell count and marginally increased erythrocyte sedimentation rate (ESR). Rest of the haematological and biochemical markers were within normal limits. Blood sample was sent for culture and sensitivity which showed no growth. Anteroposterior and lateral views of plain radiograph of the right leg showed normal tibia and fibula with subtle irregular altered soft tissue density in the lateral aspect of the mid third of the leg (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Incision and drainage was performed the following day under general anaesthesia. Thick purulent discharge was drained and about 5&#xA0;ml of the discharge was sent for culture and sensitivity. The wound was left open and dressed appropriately (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Plain radiograph anteroposterior projection demonstrating patchy irregular increased soft tissue densities in the lateral aspect of the middle third of the right leg as marked by the <italic>arrow</italic>
</p></caption><graphic xlink:href="13104_2016_2022_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Timeline of case management</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Time</th><th align="left">Process followed</th><th align="left">Observation and management</th></tr></thead><tbody><tr><td align="left" rowspan="6">Day 1</td><td align="left">History</td><td align="left">Fever, pain and swelling for 3&#xA0;days</td></tr><tr><td align="left">Physical examination</td><td align="left">Swelling with erythema, warmth and tenderness</td></tr><tr><td align="left">Blood count, erythrocyte sedimentation rate</td><td align="left">Raised white cell count<break/>Marginally elevated erythrocyte sedimentation rate</td></tr><tr><td align="left">X-ray</td><td align="left">Normal tibia and fibula with subtle irregular altered soft tissue density in the lateral aspect of the mid-third of the leg</td></tr><tr><td align="left">Blood culture</td><td align="left">No growth after 7&#xA0;days of incubation</td></tr><tr><td align="left">Treatment</td><td align="left">Patient was empirically given parenteral cefotaxime, metronidazole and gentamicin</td></tr><tr><td align="left" rowspan="3">Day 2</td><td align="left">Incision and drainage under general anaesthesia</td><td align="left">Thick purulent discharge was obtained and sent for culture and sensitivity</td></tr><tr><td align="left">Gram stain</td><td align="left">Plenty of pus cells and gram negative bacilli were seen</td></tr><tr><td align="left">Culture</td><td align="left">On incubation</td></tr><tr><td align="left">Day 3</td><td align="left">Genus identification by conventional method</td><td align="left">
<italic>Chryseobacterium</italic> spp.<break/>Subjected for VITEK-2 identification and antibiotic sensitivity testing</td></tr><tr><td align="left">Day 4</td><td align="left">Species identification by conventional and VITEK-2</td><td align="left">
<italic>C. indologenes</italic>
<break/>Minimum inhibitory concentration values by VITEK-2 as in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>
</td></tr><tr><td align="left">Day 5</td><td align="left">Switching of antibiotics</td><td align="left">Cefotaxime was changed over to ceftazidime<break/>Gentamicin was discontinued</td></tr><tr><td align="left">Day 5&#x2013;12</td><td align="left">Local examination</td><td align="left">Wound was healing well, secondary closure done and patient was discharged</td></tr></tbody></table></table-wrap></p>
      <p>Gram staining of the purulent material showed numerous pus cells and gram negative bacilli. Inoculation in blood agar showed dark yellow pigmented colonies with no hemolysis (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). On nutrient agar yellow pigmented colonies were seen and were noticed to turn to red when 10&#xA0;% potassium hydroxide (KOH) was added on to the culture (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). It did not grow in Mac Conkey agar. The isolate was non-motile, catalase and oxidase positive, indole positive, methyl red negative and Voges&#x2013;Proskauer&#x2019;s negative. Urea was not hydrolysed and citrate was not utilized. On triple sugar iron agar, glucose was utilised with gas production. The organism was identified by both conventional method and VITEK-2 systems version: 07.01 as <italic>C. indologenes</italic>.<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Blood agar showing non-haemolytic <italic>yellow</italic> pigmented colonies of <italic>C. indologenes</italic>
</p></caption><graphic xlink:href="13104_2016_2022_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>
<italic>Yellow</italic> pigmented colonies of <italic>C. indologenes</italic> turning to <italic>red</italic> upon addition of 10&#xA0;% potassium hydroxide</p></caption><graphic xlink:href="13104_2016_2022_Fig3_HTML" id="MO3"/></fig></p>
      <p>Genus was presumptively identified as Chryseobacterium after 24&#xA0;h and genus confirmation, species identification and sensitivity results were available in 48&#xA0;h. The minimum inhibitory concentration (MIC) values by VITEK-2 system are in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Minimum inhibitory concentration values by VITEK-2 system</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Antibiotic</th><th align="left">Minimum inhibitory concentration value (&#xB5;g/ml)</th><th align="left">Interpretation</th></tr></thead><tbody><tr><td align="left">Gentamicin</td><td align="left">&#x2265;16</td><td align="left">Resistant</td></tr><tr><td align="left">Amikacin</td><td align="left">&#x2265;64</td><td align="left">Resistant</td></tr><tr><td align="left">Ceftazidime</td><td align="left">4</td><td align="left">Susceptible</td></tr><tr><td align="left">Piperacillin&#x2013;tazobactam</td><td align="left">64</td><td align="left">Intermediate</td></tr><tr><td align="left">Cefaperazone&#x2013;sulbactam</td><td align="left">32</td><td align="left">Intermediate</td></tr><tr><td align="left">Imipenem</td><td align="left">1</td><td align="left">Susceptible</td></tr><tr><td align="left">Meropenem</td><td align="left">&#x2265;16</td><td align="left">Resistant</td></tr><tr><td align="left">Doripenem</td><td align="left">&#x2265;8</td><td align="left">Resistant</td></tr><tr><td align="left">Minocycline</td><td align="left">&#x2264;1</td><td align="left">Susceptible</td></tr><tr><td align="left">Levofloxacin</td><td align="left">0.25</td><td align="left">Susceptible</td></tr><tr><td align="left">Ciprofloxacin</td><td align="left">&#x2264;0.25</td><td align="left">Susceptible</td></tr><tr><td align="left">Cotrimoxazole</td><td align="left">&#x2264;20</td><td align="left">Susceptible</td></tr><tr><td align="left">Aztreonam</td><td align="left">&#x2265;64</td><td align="left">Resistant</td></tr></tbody></table></table-wrap></p>
      <p>Our isolate was susceptible to imipenem and resistant to meropenem and doripenem. <italic>Chryseobacterium</italic> species are intrinsically resistant to most beta lactams including carbapenems due to the production of chromosomally mediated metallobetalactamases (MBL). The isolate was a MBL producer which was confirmed by double disk diffusion method with ethylene diamine tetraacetic acid (EDTA).</p>
      <p>Patient was empirically started on parenteral cefotaxime, metronidazole and gentamicin, was changed over to intravenous ceftazidime 1&#xA0;g twice daily and metronidazole infusion 500&#xA0;mg thrice daily for 5&#xA0;days based on the sensitivity report following which significant clinical improvement was noted. Subsequently secondary closure was done 10&#xA0;days later. The wound healed well and the patient was discharged on oral antibiotics with follow up. Consent for publication was obtained from the patient&#x2019;s parent.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>Infection due to <italic>C. indologenes</italic> in humans is a rare occurrence and is usually nosocomial. These are mainly found in soil, plants, water and foodstuffs. They are not found in human flora. Within the hospital premises, they exist in water systems and wet surfaces and can survive in chlorinated water [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p><italic>Chryseobacterium</italic> species are gram-negative, aerobic, non-motile, oxidase positive, catalase positive, indole positive, producing a distinct yellow orange pigment due to production of flexirubin. Indole was produced in tryptophan broth. The genus <italic>Chryseobacterium</italic> belongs to the family <italic>Flavobacteriaceae</italic>. The commonly isolated species includes <italic>C. meningosepticum</italic>, <italic>C. multivorum</italic>, <italic>C. odoratum</italic>, <italic>C. breve</italic> and group IIb <italic>Chryseobacterium</italic> species which includes <italic>C. indologenes</italic> and <italic>C. gleum</italic>. Of these <italic>C. meningosepticum</italic> is the most pathogenic causing neonatal meningitis [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p>Chryseobacterium infections are frequently associated with the presence of indwelling devices like intra-vascular catheters etc., in immunocompromised patients or in patients on long-term broad-spectrum antibiotics. Factors influencing the development of Chryseobacterium infection include a suitable entry port, invasive procedures, neutropenia, production of biofilm on foreign materials, prolonged use of antibiotics and immunodeficiency [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Infections associated with <italic>Chryseobacterium</italic> species include bacteremia, wound sepsis, indwelling device associated infections, ocular infections and intra-abdominal infections. In our patient it was associated with cellulitis, soft tissue infection and abscess formation. They are usually isolated from clinical specimens but rarely from blood as were in our case [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
      <p>Most of the <italic>C. indologenes</italic> infections described in literature were hospital acquired and were seen in patients with underlying debilitating diseases [<xref ref-type="bibr" rid="CR4">4</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>]. Mostly our isolate is community acquired, as the sample grew Chryseobacterium from pus collected intraoperatively on the second day of admission. During the above said period, environmental surveillance samples did not grow Chryseobacterium.</p>
      <p>Interestingly our patient was not immunosuppressed or was on any long term antibiotics or with indwelling devices, making this case unusual in presentation. Douvoyiannis et al. [<xref ref-type="bibr" rid="CR10">10</xref>] had reported the first case of <italic>C. indologenes</italic> in a 33&#xA0;day old infant in 2010. Hendaus et al. [<xref ref-type="bibr" rid="CR11">11</xref>] reported the second case of <italic>C. indologenes</italic> infection from healthy newborn in 2013. Ours would be the third case of <italic>C. indologenes</italic> infection reported from an immunocompetent paediatric patient.</p>
      <p>Not much data is available in literature on the choice of appropriate antibiotic for empirical treatment in <italic>C. indologenes</italic> infections [<xref ref-type="bibr" rid="CR12">12</xref>]. This uncertainty is attributed to the wide spectrum of antimicrobial resistance, lack of gold standard susceptibility testing, unpredictable nature and non-establishment of MIC breakpoints for these organisms [<xref ref-type="bibr" rid="CR13">13</xref>]. Further, biofilm and proteases production by <italic>C. indologenes</italic> species reduces its antimicrobial susceptibility [<xref ref-type="bibr" rid="CR14">14</xref>]. Based on the results of SENTRY antimicrobial surveillance program during 1997&#x2013;2001, the highest prevalence of Chryseobacterium was seen among the elderly. The most appropriate antibiotics that can be used for treating Chryseobacterium infections are newer fluoroquinolones (MIC 90&#x2013;1&#xA0;&#xB5;g/ml) followed by rifampin (MIC 90&#x2013;2&#xA0;&#xB5;g/ml). <italic>C. indologenes</italic> isolates showed adequate susceptibilities to trimethoprim-sulfamethoxazole, ciprofloxacin and piperacillin&#x2013;tazobactam [<xref ref-type="bibr" rid="CR15">15</xref>]. Variable susceptibility to vancomycin has been reported in literature [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
      <p><italic>Chryseobacterium indologenes</italic> is invariably resistant to aminoglycosides, shows varying degree of resistance to carbapenems, cephalosporins, piperacillin&#x2013;tazobactam and are susceptible to fluroquinolones and cotrimoxazole. Based on the sensitivity pattern reported in SENTRY [<xref ref-type="bibr" rid="CR15">15</xref>] and other literatures [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], there was no evident difference for community acquired isolates as compared with hospital acquired strains.</p>
      <p>In this study, the isolate was resistant to meropenem and susceptible to imipenem by VITEK-2 systems. This could be due to different mechanisms involved in imipenem and meropenem resistance. Meropenem resistance is due to efflux systems and imipenem resistance is by porin mutations. Over expression of MexAB-OprM, an efflux system pumps out meropenem but not imipenem [<xref ref-type="bibr" rid="CR18">18</xref>]. As the isolate was confirmed to be a MBL producer by imipenem-EDTA double disc diffusion test, all the carbapenems were reported as resistant for therapeutic purpose.</p>
      <p>Disk diffusion methods are not reliable and thus susceptibility testing by broth micro dilution method should be performed [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusion</title>
      <p>Listed as one of the nosocominal infections, <italic>C. indologenes</italic> infections known for its rare and sporadic incidence can cause potentially serious infections in humans. As described they can cause significant infections in immunocompetent individuals as well. More extensive and long term studies are required to understand the demographics, pathogenicity, virulence factors, arbitrary antimicrobial resistance and appropriate antimicrobial therapy.
</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ESR</term>
          <def>
            <p>erythrocyte sedimentation rate</p>
          </def>
        </def-item>
        <def-item>
          <term>EDTA</term>
          <def>
            <p>ethylene diamine tetraacetic acid</p>
          </def>
        </def-item>
        <def-item>
          <term>MBL</term>
          <def>
            <p>metallo beta-lactamase</p>
          </def>
        </def-item>
        <def-item>
          <term>MIC</term>
          <def>
            <p>minimum inhibitory concentration</p>
          </def>
        </def-item>
        <def-item>
          <term>KOH</term>
          <def>
            <p>potassium hydroxide</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Authors&#x2019; contributions</title>
      <p>GS, SM, VR&#x2014;Collected data and involved in preparation of manuscript. NMJ, JME&#x2014;Finalising the manuscript. All authors read and approved the final version of the manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>We acknowledge the faculty in Departments of Orthopedics and Radio-diagnosis, Sri Venkateshwaraa Medical College Hospital and Research Center, Ariyur, Pondicherry for their kind cooperation during data collection.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar3">
        <title>Availability of data and materials</title>
        <p>All the data are included in the manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Consent to publish</title>
        <p>Written informed consent was obtained from the patient&#x2019;s legal guardian for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calder&#xF3;n</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rojas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rosso</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Losada</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title><italic>Chryseobacterium indologenes</italic> infection in a newborn: a case report</article-title>
          <source>J Med Case Rep</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>10</fpage>
          <pub-id pub-id-type="doi">10.1186/1752-1947-5-10</pub-id>
          <pub-id pub-id-type="pmid">21235776</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Jeng</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Clinical and microbiological characteristics of <italic>Chryseobacterium indologenes</italic> bacteremia</article-title>
          <source>J Microbiol Immunol Infect</source>
          <year>2010</year>
          <volume>43</volume>
          <fpage>498</fpage>
          <lpage>505</lpage>
          <pub-id pub-id-type="doi">10.1016/S1684-1182(10)60077-1</pub-id>
          <pub-id pub-id-type="pmid">21195977</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christakis</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Perlorentzou</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Chalkiopoulou</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Athanasiou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Legakis</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title><italic>Chryseobacterium indologenes</italic> non-catheter-related bacteremia in a patient with a solid tumor</article-title>
          <source>J Clin Microbiol</source>
          <year>2005</year>
          <volume>43</volume>
          <fpage>2021</fpage>
          <lpage>2023</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.43.4.2021-2023.2005</pub-id>
          <pub-id pub-id-type="pmid">15815050</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsueh</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Hsiue</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Teng</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>WC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Flavobacterium indologenes</italic> bacteremia: clinical and microbiological characteristics</article-title>
          <source>Clin Infect Dis</source>
          <year>1996</year>
          <volume>23</volume>
          <fpage>550</fpage>
          <lpage>555</lpage>
          <pub-id pub-id-type="doi">10.1093/clinids/23.3.550</pub-id>
          <pub-id pub-id-type="pmid">8879779</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gunduz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gulbas</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Catheter-related bacteremia due to <italic>Chryseobacterium indologenes</italic> in a bone marrow transplant recipient</article-title>
          <source>Bone Marrow Transplant</source>
          <year>2006</year>
          <volume>37</volume>
          <fpage>435</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.bmt.1705261</pub-id>
          <pub-id pub-id-type="pmid">16415896</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cascio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stassi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Crisafulli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rulli</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ruggeri</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Chryseobacterium indologenes</italic> bacteraemia in a diabetic child</article-title>
          <source>J Med Microbiol</source>
          <year>2005</year>
          <volume>54</volume>
          <fpage>677</fpage>
          <lpage>680</lpage>
          <pub-id pub-id-type="doi">10.1099/jmm.0.46036-0</pub-id>
          <pub-id pub-id-type="pmid">15947433</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsueh</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Teng</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Luh</surname>
              <given-names>KT</given-names>
            </name>
          </person-group>
          <article-title>Increasing incidence of nosocomial <italic>Chryseobacterium indologenes</italic> infections in Taiwan</article-title>
          <source>Eur J Clin Microbiol Infect Dis</source>
          <year>1997</year>
          <volume>16</volume>
          <fpage>568</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02447918</pub-id>
          <pub-id pub-id-type="pmid">9323467</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsueh</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Teng</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Luh</surname>
              <given-names>KT</given-names>
            </name>
          </person-group>
          <article-title>Clinical and microbiological characteristics of <italic>Flavobacterium indologenes</italic> infections associated with indwelling devices</article-title>
          <source>J Clin Microbiol</source>
          <year>1996</year>
          <volume>34</volume>
          <fpage>1908</fpage>
          <lpage>1913</lpage>
          <pub-id pub-id-type="pmid">8818879</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aydin Teke</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oz</surname>
              <given-names>FN</given-names>
            </name>
            <name>
              <surname>Metin</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Bayhan</surname>
              <given-names>GI</given-names>
            </name>
            <name>
              <surname>Gayretli Aydin</surname>
              <given-names>ZG</given-names>
            </name>
            <name>
              <surname>Oguz</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Chryseobacterium indologenes</italic> septicaemia in an infant</article-title>
          <source>Case Rep Infect Dis</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>270521</fpage>
          <pub-id pub-id-type="pmid">25114816</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Douvoyiannis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kalyoussef</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Philip</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mayers</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title><italic>Chryseobacterium indologenes</italic> bacteremia in an infant</article-title>
          <source>Int J Infect Dis</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>e531</fpage>
          <lpage>e532</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijid.2009.06.015</pub-id>
          <pub-id pub-id-type="pmid">19729329</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hendaus</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Zahraldin</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title><italic>Chryseobacterium indologenes</italic> meningitis in a healthy newborn: a case report</article-title>
          <source>Oman Med J</source>
          <year>2013</year>
          <volume>28</volume>
          <fpage>133</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="doi">10.5001/omj.2013.35</pub-id>
          <pub-id pub-id-type="pmid">23599885</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Green</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Nolan</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
          <article-title>Cellulitis and bacteraemia due to <italic>Chryseobacterium</italic><italic>indologenes</italic></article-title>
          <source>J Infect</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>219</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="doi">10.1053/jinf.2001.0822</pub-id>
          <pub-id pub-id-type="pmid">11545560</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="other">Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. In: 17th informational supplement. CLSI Document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.</mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Ferreira</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Brandao</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Lobo</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title><italic>Chryseobacterium indologenes</italic> infection: a case report</article-title>
          <source>Rev Bras Ter Intensiva</source>
          <year>2010</year>
          <volume>22</volume>
          <fpage>96</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.1590/S0103-507X2010000100016</pub-id>
          <pub-id pub-id-type="pmid">25303706</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirby</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Sader</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Antimicrobial susceptibility and epidemiology of a worldwide collection of <italic>Chryseobacterium</italic> spp: report from the SENTRY antimicrobial surveillance program (1997&#x2013;2001)</article-title>
          <source>J Clin Microbiol</source>
          <year>2004</year>
          <volume>2004</volume>
          <issue>42</issue>
          <fpage>445</fpage>
          <lpage>448</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.42.1.445-448.2004</pub-id>
          <pub-id pub-id-type="pmid">14715802</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhuyar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>VK</given-names>
            </name>
          </person-group>
          <article-title>Urinary tract infection by <italic>Chryseobacterium indologenes</italic></article-title>
          <source>Indian J Med Microbiol</source>
          <year>2012</year>
          <volume>30</volume>
          <fpage>370</fpage>
          <lpage>372</lpage>
          <pub-id pub-id-type="doi">10.4103/0255-0857.99511</pub-id>
          <pub-id pub-id-type="pmid">22885214</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diogo</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Community-acquired <italic>Chryseobacterium indologenes</italic> in an immunocompetent patient</article-title>
          <source>JMM Case Rep</source>
          <year>2014</year>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez-Martinez</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Poirel</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nordmann</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Molecular epidemiology and mechanisms of carbapenem resistance in <italic>Pseudomonas aeruginosa</italic></article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>4783</fpage>
          <lpage>4788</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.00574-09</pub-id>
          <pub-id pub-id-type="pmid">19738025</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fraser</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Reappraisal of the antimicrobial susceptibilities of <italic>Chryseobacterium</italic> and <italic>Flavobacterium</italic> species and methods for reliable susceptibility testing</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>1997</year>
          <volume>41</volume>
          <fpage>2738</fpage>
          <lpage>2741</lpage>
          <pub-id pub-id-type="pmid">9420049</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
